CARE Ratings reaffirms Crest Ventures at CARE BBB

What happened

Crest Ventures (BSE: CREST) informed the stock exchanges on 10 November 2026 at 12:21 PM that CARE Ratings has reaffirmed its credit rating at CARE BBB.

From the filing: "Stable Reaffirmed B) Withdrawn the credit rating assigned to Debentures - Non-Convertible Debentures (ISIN: INE559D08024) ("NCDs"), as these NCDs were redeemed in full on December 20, 2025 and there is no amount outstanding under the said NCDs as on date."

Company snapshot

Crest Ventures is a small-cap company, with a market value of about ₹1,068 crore.

The stock last traded at ₹375.6, against a 52-week range of ₹298.2–₹418 (10.2% below the high).

Before this filing the shares had moved +6.8% over the month and +2.8% over three months. Average daily turnover over the last 20 sessions was about ₹0.12 crore.

Promoters held 69.84% at the end of Q2 FY27. Foreign institutions owned 1.61% and domestic institutions 0.00%.

What history shows

This is not the company's first credit rating disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Market-wide, 1,441 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Whether other agencies take a similar view on the company's credit.

In the news

Recent coverage elsewhere (links open the original publisher):

• Crest Ventures Limited’s Eight Projects Run Through FY30 — Multibagg AI, 6 Nov 2026
• Crest Ventures Q2FY27 net profit jumps 162% to ₹741 lakh — scanx.trade, 8 Nov 2026
• Crest Ventures Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 — www.marketscreener.com, 5 Nov 2026
• Crest Ventures Q2 Results FY27: Revenue Up 26.24% to Rs 37.29 Cr, PAT Rs 9.37 Cr — Univest, 5 Nov 2026
• Crest Ventures Q2 FY27: Profit Surge Masks Valuation Concerns — MarketsMojo, 6 Nov 2026

Source

• Exchange filing (PDF)